Trial
NCT04900428
Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Sorrento Therapeutics, Inc.
Collaborators
—
Condition
Covid19
Intervention
COVI-DROPS
Why stopped
Study was terminated at interim analysis due to drops not working on new variants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-30